Skip to main content
. 2018 Nov 3;11:1756286418809580. doi: 10.1177/1756286418809580

Table 2.

Results of ENG, HRUS and CCM of the propionate-treated AMSAN patient at baseline and follow-up visit. Values outside the normal range are highlighted.

Baseline 2 month follow up
ENG Tibial F (ms) 43.3 52.8
ankle-AH DML (ms) 4.4 4.6
cMAP (mV) 2.9 4.5
mCV (m/s) 44.7 48.3
Sural sNAP (ms) 8.6 17
sCV (m/s) 56.0 50.0
Median F (ms) 26.5 n.a.
wrist-APB DML (ms) 3.5 n.a.
cMAP (mV) 6.6 n.a.
CV (m/s) 53.1 n.a.
Median sensory sNAP (ms) 5.0 n.a.
sCV (m/s) 63.3 n.a.
Ulnar F (ms) 25.3 28.1
wrist-ADM DML (ms) 3.2 2.8
cMAP (mV) 3.8 7.3
CV (m/s) 59.1 61.7
Ulnar sensory sNAP (ms) 3.7 2.3
sCV (m/s) 68.5 71.8
CCM Corneal nerve fiber length (mm/mm²) 11.34 15.93
Corneal nerve fiber density (nerves/mm²) 16.25 28.75
Corneal branch density (branch points/mm²) 15.0 53.75
HRUS CSA (mm²) right left right Left
Median Carpal tunnel 7.3 11.8 8.7 9.1
Forearm 7.1 8.3 7.4 8
Upper arm 10.4 9.8 13.1 14.0
Ulnar Guyon’s canal 5.6 4.6 4.8 3.8
Forearm 5.4 4.5 4.5 6.0
Elbow 8.8 9.1 7.5 8.0
Upper arm 5.7 6.0 5.7 5.0
Radial Spiral groove 6.5 3.8 4.0 4.1
Fibular Fibular head 6.7 9.0 7.0 8.8
Popliteal fossa 5.5 7.1 6.4 5.5
Tibial Popliteal fossa 23.7 22 17.1 17.9
Tarsal tunnel 6.3 9.3 7.7 10.8
Sural Middle lower leg 1.5 1 2.3 2.7

AMSAN, acute motor and sensory axonal neuropathy; CCM, confocal corneal microscopy; ENG, electroneurography; HRUS, high-resolution nerve ultrasound.